A week in which Swiss sensors found deep pockets, “boring” logistics became interesting, and Europe’s commercialization machine kept reminding everyone that market access is only the beginning. Weekly snapshot of MedTech and Digital Health NEWS in Europe People on the move MedTech leadership: Coloplast Coloplast named Gavin Wood as its next President and CEO, effective…
This week: Europe writes bigger cheques for edge AI, surgeons get sharper intra-op vision, and regulators quietly upgrade the “plumbing” that makes scale possible. People on the move Precision IO Group (Quantum Surgical + NeuWave Medical) Kurt Azarbarzin appointed CEO as the new parent company forms around Quantum’s acquisition of J&J’s NeuWave Medical. The industrial…
Compliance tooling and workflow automation quietly had a massive week, capped off by the UK’s loud return to the CE mark conversation with a push for indefinite regulatory recognition. People on the move Dymicron Peter Wehrly The spinal motion-preservation technology company appointed the MedTech veteran to its Board of Directors to help navigate its US…
European healthcare shifts from “growth at all costs” toward commercial execution as precision pathology, ocular structural integrity, and public-market readiness dominate the landscape. People on the move Amadeus Capital Partners / Pierre Socha — The veteran HealthTech investor has been appointed to the Royal Society’s Science, Industry and Translation Committee. Socha will advise on financing…
Clinical-trial AI cash, senior care safety tech, and a trio of MDR certifications: Europe’s week mixed capital, commercialization, and infrastructure-level digital transformation. People on the move Guerbet Karim Boussebaa appointed CEO, effective Feb 2, to sharpen execution in imaging contrast and interventional solutions as the firm targets high-growth AI integration. Medicines for Europe Steffen Saltofte…
For years, European imaging AI founders have been trapped by Rule 11 of the MDR, which effectively pushed almost all diagnostic software into Class IIa or higher. However, the regulatory landscape shifted dramatically this week as the European Commission’s simplification proposal moved toward implementation, signaling a fundamental win for the digital health sector. 1. The…
The European ecosystem is trading complexity for clarity this week: a landmark proposal to “de-clog” the MDR/IVDR bottleneck arrives alongside major CE marks in diabetes, while surgical imaging and pharmacy infrastructure secure fresh growth capital to scale. People on the move Wandercraft / Chuck Witkowski The French-American exoskeleton pioneer, famous for its self-balancing “Eve” system,…
A heavyweight week for the “reimbursement-first” era: chronic care platforms are hitting mega-round scale, NICE is formalizing the digital MSK pathway, and a French-made mitral valve just secured its ticket to the EU market. People on the move ONWARD Medical / Ali KiboroThe Dutch-Swiss neurotech leader has appointed Ali Kiboro (ex-AliveDx, Quest Diagnostics) as CFO…
Two watchdogs, one playbook. On 14 January 2026, the European Medicines Agency and the U.S. FDA jointly published “Guiding principles of good AI practice in drug development,” a concise set of 10 rules for using AI across the medicines lifecycle, from data collection and model building to post-market monitoring. It’s not a binding guidance, but…
Quiet but productive: seed checks for prevention and preclinical tools, one neat CE mark, and a fresh EU call. People on the move Qureight / Rebecca Simmons Ex-Riverlane operator becomes COO to scale the Cambridge clinical-trial imaging platform. [Source] NanoSyrinx / Thomas Farrell The UK-based intracellular drug delivery innovator appointed Thomas Farrell as CEO to…